Zobrazeno 1 - 9
of 9
pro vyhledávání: '"James F. Catroppo"'
Autor:
Balázs Győrffy, Eugenia V. Broude, James F. Catroppo, Mengqian Chen, Alexander A. Chumanevich, Martina McDermott, Igor B. Roninson, Michael Shtutman
Publikováno v:
Current Cancer Drug Targets. 15:739-749
CDK8 and its paralog CDK19, in complex with CCNC, MED12 and MED13, are transcriptional regulators that mediate several carcinogenic pathways and the chemotherapy-induced tumor-supporting paracrine network. Following up on our previous observation tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16a51f6943651955512a9b040c5594d
https://doi.org/10.2174/156800961508151001105814
https://doi.org/10.2174/156800961508151001105814
Autor:
Eugenia V. Broude, Martina McDermott, Balazs Gyorffy, Mengqian Chen, James F. Catroppo, Chang-uk Lim, Alexander A. Chumanevich, David Oliver, Igor B. Roninson
Publikováno v:
Cancer Research. 75:P4-15
CDK8, along with its paralog CDK19, is a cyclin dependent kinase which, in contrast to other members of the CDK family does not regulate cell cycle progression. CDK8 acts as a pleiotropic transcription regulator potentiating the induction of transcri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76f75cb86608f7a3a5dd2634e41c7080
https://doi.org/10.1158/1538-7445.sabcs14-p4-15-13
https://doi.org/10.1158/1538-7445.sabcs14-p4-15-13
Autor:
Jamie L. McClellan, Jiajia Zhang, Mitzi Nagarkatti, Udai P. Singh, E. Angela Murphy, Elizabeth E. Zumbrun, Ibrahim Altamemi, Prakash S. Nagarkatti, James F. Catroppo
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 350:99-109
The pleiotropic effects of resveratrol include anti-inflammatory, antioxidant, and anticancer activities, and thus unique possibilities exist to explore mechanistic pathways of chemoprevention. The aim of this study was to investigate the role of mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6bede89db3216a53b6943bc5d61cdbe
https://doi.org/10.1124/jpet.114.213306
https://doi.org/10.1124/jpet.114.213306
Autor:
Allison G. Jackson, Lynn K. Thomas, R. Stephen Smith, Shawn Chillag, James B. McCallum, Carol McMahon, Thomas Cook, Caroline K. Powell, Michael Blaivas, Mary Beth Poston, William R. Jennings, Paul Bornemann, James F. Catroppo, Ali A. Rizvi, L. Britt Wilson, Paul V. Catalana, Victor Rao, David Schrift, Donald J. Kenney, Patrick Hunt, Richard Hoppmann, Fernando A. Navarro, Jeffrey W. Hall, James M. Nottingham, Erika L. Blanck, Kerry M. Sims, Joshua T. Thornhill, Brian D. Keisler, Keith Barron, Kelsey Hagon, Stephen Harris, James R. Augustine, Michael Wagner, Stanley D. Fowler, William B. Owens, Steven P. Wilson, Judith T. Burgis, Nancy Richeson, Danielle Davis, Duncan Howe, James Kreiner, Eric K. Brown, Floyd E. Bell, C. Osborne Shuler, Robert I. Haddad, Matthew D. Garber, Shaun Riffle, Ruth A. Riley, Celia Hartman, Norman W. Pedigo, Francis H. Neuffer, James R. Wells
Publikováno v:
Critical Ultrasound Journal
Interest in ultrasound education in medical schools has increased dramatically in recent years as reflected in a marked increase in publications on the topic and growing attendance at international meetings on ultrasound education. In 2006, the Unive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc443b8605b69c123221451feb375b7d
https://doi.org/10.1186/s13089-015-0035-3
https://doi.org/10.1186/s13089-015-0035-3
Publikováno v:
Archives of Pathology & Laboratory Medicine. 129:348-353
Context.—Dendriform pulmonary ossification (DPO) is an uncommon form of diffuse pulmonary ossification that typically affects the pulmonary interstitium in a setting of interstitial fibrosis. Objective.—To determine the incidence and characterist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ade5b1d2f993a409fd3304e0e6c9003
https://doi.org/10.5858/2005-129-348-dpoafo
https://doi.org/10.5858/2005-129-348-dpoafo
Autor:
Jonathan F. Lara, James F. Catroppo
Publikováno v:
Diagnostic Cytopathology. 25:285-291
Metaplastic carcinoma of the breast (MCB) is a well recognized but uncommon aberrant manifestation of poorly differentiated invasive carcinoma containing both epithelial (ductal) and mesenchymal elements as well as a transitional form between them. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c6f18bc65bf1d69d3f67602c238a645
https://doi.org/10.1002/dc.2056
https://doi.org/10.1002/dc.2056
Autor:
Eugenia V. Broude, Msj McDermott, Vimala Kaza, Igor B. Roninson, Alexander A. Chumanevich, David Oliver, Mengqian Chen, Michael Shtutman, Balazs Gyorffy, James F. Catroppo, Donald C. Porter
Publikováno v:
Cancer Research. 76:P5-04
Cyclin-dependent kinase 8 (CDK8) and its paralog CDK19 are transcriptional regulators that, in complex with CCNC, MED12 and MED13, mediate several carcinogenic signalling pathways such as NFκβ, TGFβ/BMP, WNT/β-catenin, HIF1A and serum growth fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60ec029ada43f47af469167362de8a45
https://doi.org/10.1158/1538-7445.sabcs15-p5-04-07
https://doi.org/10.1158/1538-7445.sabcs15-p5-04-07
Autor:
James F. Catroppo, C T Patrick Ringer, Robert Goldenkranz, Theodore Wright, Victor Casas, Ludmilla Olesnicky
Publikováno v:
Diagnostic cytopathology. 26(5)
“Low-grade myxoid neoplasm with recurrent potential” (cellular myxoma) is a term recently used to describe a subset of soft tissue lesions with histology intermediate between intramuscular myxoma and low-grade myxofibrosarcoma or myxoid malignant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e98680b927bfcb875558b3f0d988a98
https://pubmed.ncbi.nlm.nih.gov/11992372
https://pubmed.ncbi.nlm.nih.gov/11992372
Autor:
Alexander A. Chumanevich, Chang-uk Lim, Eugenia V. Broude, Igor B. Roninson, Mengqian Chen, James F. Catroppo, Zhengguan Yang, Balazs Gyorffy, Martina McDermott
Publikováno v:
Cancer Research. 74:2101-2101
The majority of breast cancers (BrCa) overexpress estrogen receptor (ER)α, which regulates transcription and drives estrogen-stimulated proliferation of ER+ tumor cells. ER+ patients usually receive adjuvant anti-estrogen therapy based on ER modific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91e6ccef3702f3998046eef9f67ef189
https://doi.org/10.1158/1538-7445.am2014-2101
https://doi.org/10.1158/1538-7445.am2014-2101